Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (AGE's)

Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (AGE's)

US Patent 6693106 · Granted Feb 17, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compound for treating cancer and diabetes2023
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and2022
Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthes2022
Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthes2021
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and2020
4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and2019
Modulators of development of adipocyte and cancer cells2018
Methods of quantifying N2-(1-carboxyethyl)-2′-deoxy-guanosine (CEdG) and synthes2018
Compound for treating cancer and diabetes2017
Substituted phthalazines for inducing insulin secretion and protecting beta-cell2016
Lisofylline analogs and methods for use2015
Lisofylline analogs and methods for use2014